BlackRock Institutional Trust’s Fibrocell Science Inc. FCSC Stock Holding History

BlackRock Institutional Trust’s Portfolio FCSC Stock Details FCSC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$86K	Hold	9,089	–	–	﹤0.01%	3664
2016 Q3	$98K	Hold	9,089	–	–	﹤0.01%	3700
2016 Q2	$157K	Sell	9,089 -11,815	-57%	-$368K	﹤0.01%	3659
2016 Q1	$784K	Sell	20,904 -191	-0.9%	-$7.63K	﹤0.01%	3349
2015 Q4	$1.44M	Buy	21,095 +1,625	+8%	+$117K	﹤0.01%	3230
2015 Q3	$1.12M	Buy	19,470 +7,730	+66%	+$684K	﹤0.01%	3306
2015 Q2	$928K	Buy	+11,740	New	+$790K	﹤0.01%	3375
2015 Q1	–	Sell	-59	Closed	-$2K	–	3922
2014 Q4	$2K	Sell	59 -2,083	-97%	-$84.2K	﹤0.01%	3885
2014 Q3	$93K	Buy	+2,142	New	+$100K	﹤0.01%	3678
2014 Q2	–	Sell	-13,833	Closed	-$1.08M	–	4075
2014 Q1	$1.08M	Buy	13,833 +153	+1%	+$11.9K	﹤0.01%	3395
2013 Q4	$833K	Buy	13,680 +1,816	+15%	+$106K	﹤0.01%	3447
2013 Q3	$779K	Buy	11,864 +983	+9%	+$79.5K	﹤0.01%	3430
2013 Q2	$999K	Buy	+10,881	New	+$900K	﹤0.01%	3335

Other funds holding FCSC

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

SCA

STALEY CAPITAL ADVISERS Pittsburgh, Pennsylvania $2.36B AUM 23.72% 1-Year Est. Return

BlackRock Institutional Trust's FCSC Position: Q4 2016 in Review

BlackRock Institutional Trust held its Fibrocell Science Inc. (FCSC) position steady in Q4 2016 at 9,089 shares worth $86K. The position accounts for ﹤0.01% of the portfolio, ranked #3664.

BlackRock Institutional Trust first reported a position in FCSC in Q2 2013 and has held it in 13 quarters since. The position peaked at $1.44M in Q4 2015. 30 funds tracked by Wall St. Rank hold FCSC as of Q4 2016.

BlackRock Institutional Trust held 9,089 shares of Fibrocell Science Inc. worth $86K as of Q4 2016.
BlackRock Institutional Trust left its Fibrocell Science Inc. share count unchanged in Q4 2016.
Fibrocell Science Inc. made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #3664 holding.
BlackRock Institutional Trust first reported a position in Fibrocell Science Inc. in Q2 2013 and has held it in 13 quarters since.
BlackRock Institutional Trust's Fibrocell Science Inc. position peaked at $1.44M in Q4 2015.
30 funds tracked by Wall St. Rank held Fibrocell Science Inc. as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.